Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Chinese group buys worlds No. 2 condom maker for 600 million dollar

      Chinese group buys world's No. 2 condom maker for 600 million dollar

      Ruby Khatun Khatun27 May 2017 11:24 AM IST
      SYDNEY: A Chinese consortium is buying Ansell Ltd's condom division, the world's no. 2 condom maker, for $600 million, betting on surging demand in...
      Cipla Q4 net loss narrows to Rs 61.79 cr

      Cipla Q4 net loss narrows to Rs 61.79 cr

      Ruby Khatun Khatun27 May 2017 11:23 AM IST
      New Delhi: Pharma major Cipla reported a narrowing of its consolidated net loss to Rs 61.79 crore for the fourth quarter ended March 31.The company...
      Otsuka and Proteus Digital Health® Resubmit Application to FDA for First Digital Medicine

      Otsuka and Proteus Digital Health® Resubmit Application to FDA for First Digital Medicine

      Ruby Khatun Khatun27 May 2017 9:45 AM IST
      TOKYO & REDWOOD CITY: Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health® (Proteus) have announced that the United States Food...
      Digital A Plus hosts 1st Asia Pacific Multichannel Marketing Expert Meeting for Pharma and Healthcare in Kuala Lumpur, Malaysia

      Digital A Plus hosts 1st Asia Pacific Multichannel Marketing Expert Meeting for Pharma and Healthcare in Kuala Lumpur, Malaysia

      Ruby Khatun Khatun27 May 2017 9:43 AM IST
      Bangalore: Digital A Plus Group of Companies (Digital A Plus Healthcare Malaysia, Digi A Plus Technologies Shanghai, and DAP E-nnovative Solutions...
      MAKE in India, reduce import of medical equipment to make treatment cheaper: PM Modi

      MAKE in India, reduce import of medical equipment to make treatment cheaper: PM Modi

      Ruby Khatun Khatun26 May 2017 1:53 PM IST
      Prime Minister Narendra Modi on Thursday stressed on reducing dependence on other countries for getting medical equipment so as to make treatment...
      Suven Life Sciences begins clinical trial of anti-depressant

      Suven Life Sciences begins clinical trial of anti-depressant

      Ruby Khatun Khatun26 May 2017 1:52 PM IST
      New Delhi: Drug firm Suven Life Sciences announced initiation of phase 1 clinical trial and first dosing of a chemical entity intended for the...
      Connect database of medical stores with owner, pharmacists Aadhaar: Allahabad HC

      Connect database of medical stores with owner, pharmacists' Aadhaar: Allahabad HC

      Ruby Khatun Khatun26 May 2017 1:52 PM IST
      Lucknow: The Allahabad High Court directed the Uttar Pradesh government to prepare a database of medical store owners and pharmacists, link it with...
      Strides Shasun gets USFDA nod for dementia drug

      Strides Shasun gets USFDA nod for dementia drug

      Ruby Khatun Khatun26 May 2017 1:36 PM IST
      New Delhi: Strides Shasun said it has received approval from the US health regulator for memantine hydrochloride tablets used in the treatment of...
      Startup Health Sutra Raises Rs 2 crore From Ankur Capital and Hyderabad Angels

      Startup Health Sutra Raises Rs 2 crore From Ankur Capital and Hyderabad Angels

      Ruby Khatun Khatun26 May 2017 1:28 PM IST
      Hyderabad: Early stage venture capital fund, Ankur Capital, along with Hyderabad Angels, has invested over Rs 2 crore into Fountain Head Foods, the...
      FDA approves first cancer treatment for any solid tumor with a specific genetic feature

      FDA approves first cancer treatment for any solid tumor with a specific genetic feature

      Ruby Khatun Khatun26 May 2017 9:38 AM IST
      The U.S. Food and Drug Administration (FDA) granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature...
      UK competition watchdog accuses Merck of obstructing biosimilars

      UK competition watchdog accuses Merck of obstructing biosimilars

      Ruby Khatun Khatun26 May 2017 9:32 AM IST
      LONDON: Britain's competition watchdog has accused Merck & Co of operating an unfair discount scheme for its medicine Remicade that it said was...
      USFDA panel backs Puma Biotechnology Incs breast cancer drug

      USFDA panel backs Puma Biotechnology Inc's breast cancer drug

      Ruby Khatun Khatun26 May 2017 9:31 AM IST
      WASHINGTON: Puma Biotechnology Inc's experimental breast cancer drug reduces the risk of disease recurrence and should be approved, an advisory...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok